Impact of Smoking on Treatment Adherence for Latent Tuberculosis
Author Information
Author(s): Mélanie Lavigne, Isabelle Rocher, Colin Steensma, Paul Brassard
Primary Institution: McGill University Health Center
Hypothesis
Smokers with latent tuberculosis infection (LTBI) are less likely to comply with their LTBI treatment regimen.
Conclusion
Males and smokers need to have extra supervision to ensure compliance with LTBI treatment.
Supporting Evidence
- 320 patients were recruited, and 302 (94%) completed the questionnaire.
- Smoking prevalence was 21%.
- 72% of patients were adherent to LTBI treatment.
- Women were more likely to adhere to treatment than men.
Takeaway
Smoking can make it harder for people to stick to their medicine for tuberculosis, especially for men.
Methodology
A convenience sample of patients undergoing treatment for LTBI completed a questionnaire on smoking status and adherence was assessed through pill counts and self-reports.
Potential Biases
Social desirability bias may have led to underreporting of smoking prevalence.
Limitations
Self-reported smoking status may have been biased, and factors like economic status and language barriers were not fully explored.
Participant Demographics
320 patients, mean age 35.5 years, 87% foreign born, 21% smokers.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI: 1.2–3.3
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website